Waldenström's macroglobulinemia laboratory findings: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Elevated Beta-2-microglobulin and abnormal coagulation studies are diagnostic of Waldenström's macroglobulinemia. <ref name=" | Elevated Beta-2-microglobulin and abnormal coagulation studies are diagnostic of Waldenström's macroglobulinemia. <ref name="Lb"> {{cite journal |vauthors=García-Sanz R, Montoto S, Torrequebrada A, de Coca AG, Petit J, Sureda A, Rodríguez-García JA, Massó P, Pérez-Aliaga A, Monteagudo MD, Navarro I, Moreno G, Toledo C, Alonso A, Besses C, Besalduch J, Jarque I, Salama P, Rivas JA, Navarro B, Bladé J, Miguel JF |title=Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases |journal=Br. J. Haematol. |volume=115 |issue=3 |pages=575–82 |year=2001 |pmid=11736938 |doi= |url=}}</ref> | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
===Complete blood count=== | ===Complete blood count=== | ||
*[[Normocytic normochromic anemia]]: presents in 80% of patients<ref name=" | *[[Normocytic normochromic anemia]]: presents in 80% of patients<ref name="Lb">{{cite journal |vauthors=García-Sanz R, Montoto S, Torrequebrada A, de Coca AG, Petit J, Sureda A, Rodríguez-García JA, Massó P, Pérez-Aliaga A, Monteagudo MD, Navarro I, Moreno G, Toledo C, Alonso A, Besses C, Besalduch J, Jarque I, Salama P, Rivas JA, Navarro B, Bladé J, Miguel JF |title=Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases |journal=Br. J. Haematol. |volume=115 |issue=3 |pages=575–82 |year=2001 |pmid=11736938 |doi= |url=}}</ref> | ||
*[[Leukopenia]] | *[[Leukopenia]] | ||
*[[Thrombocytopenia]]: presents in 50% of patients with bleeding diathesis | *[[Thrombocytopenia]]: presents in 50% of patients with bleeding diathesis | ||
Line 31: | Line 31: | ||
===Plasma viscosity=== | ===Plasma viscosity=== | ||
*Plasma viscosity should be measured in patients presenting with [[hyperviscosity syndrome]] whenever the monoclonal IgM protein spike is >4 g/dL. | *Plasma viscosity should be measured in patients presenting with [[hyperviscosity syndrome]] whenever the monoclonal IgM protein spike is >4 g/dL. | ||
*The normal Plasma viscosity is 1.8 centipoise. | *The normal Plasma viscosity is 1.8 centipoise. | ||
*Patients start presenting with hyperviscosity symptoms when viscosity >4 centipoise. | *Patients start presenting with hyperviscosity symptoms when viscosity >4 centipoise. |
Revision as of 15:02, 20 November 2015
Waldenström's macroglobulinemia Microchapters |
Differentiating Waldenström's macroglobulinemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Waldenström's macroglobulinemia laboratory findings On the Web |
American Roentgen Ray Society Images of Waldenström's macroglobulinemia laboratory findings |
Waldenström's macroglobulinemia laboratory findings in the news |
Blogs on Waldenström's macroglobulinemia laboratory findings |
Directions to Hospitals Treating Waldenström's macroglobulinemia |
Risk calculators and risk factors for Waldenström's macroglobulinemia laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]
Overview
Elevated Beta-2-microglobulin and abnormal coagulation studies are diagnostic of Waldenström's macroglobulinemia. [1]
Laboratory Findings
Complete blood count
- Normocytic normochromic anemia: presents in 80% of patients[1]
- Leukopenia
- Thrombocytopenia: presents in 50% of patients with bleeding diathesis
Peripheral smear
- Plasmacytoid lymphocytes
- Normocytic normochromic red blood cells
- Rouleaux formation
Chemistry lab tests
- Elevated Beta-2-microglobulin in proportion to tumor mass
- Elevated Lactate dehydrogenase
- Elevated Creatinine
- Electrolyte abnormalities:
- Hypercalcemia(4%)
- Elevated Erythrocyte Sedimentation Rate and uric acid
- Total protein levels
- Albumin-to-globulin ratio
- Rheumatoid factor, cryoglobulins, direct anti-globulin test, and cold agglutinin titre results can be positive.
- Coaglulation studies can be abnormal with elevated prothrombin time, activated partial thromboplastin time, and thrombin time.
Plasma viscosity
- Plasma viscosity should be measured in patients presenting with hyperviscosity syndrome whenever the monoclonal IgM protein spike is >4 g/dL.
- The normal Plasma viscosity is 1.8 centipoise.
- Patients start presenting with hyperviscosity symptoms when viscosity >4 centipoise.
References
- ↑ 1.0 1.1 García-Sanz R, Montoto S, Torrequebrada A, de Coca AG, Petit J, Sureda A, Rodríguez-García JA, Massó P, Pérez-Aliaga A, Monteagudo MD, Navarro I, Moreno G, Toledo C, Alonso A, Besses C, Besalduch J, Jarque I, Salama P, Rivas JA, Navarro B, Bladé J, Miguel JF (2001). "Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases". Br. J. Haematol. 115 (3): 575–82. PMID 11736938.